by Scott Larrivee | Oct 16, 2025 | News
The following is a copy of a press release issued by Clarity Pharmaceuticals Sydney, Australia 16 October 2025 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products...
by Scott Larrivee | Oct 14, 2025 | Utah, Awards & Honors
SALT LAKE CITY – October 14, 2025 – Nusano radiochemist Lauren Radford has been named a “Healthcare Hero” by Utah Business. Utah Business’s annual Healthcare Heroes Awards honor individuals making a significant impact in the fields of healthcare,...
by Scott Larrivee | Oct 14, 2025 | News
Agreement includes Actinium-225 (Ac-225) and Lutetium-177 (Lu-177) to support Ariceum’s therapeutic programs WEST VALLEY CITY, Utah and BERLIN, Germany – Oct. 14, 2025 – Nusano, a physics company transforming the production of radioisotopes, and Ariceum Therapeutics...
by Scott Larrivee | Oct 3, 2025 | Utah, Awards & Honors
SALT LAKE CITY – Oct. 3, 2025 – Today, Nusano’s Melissa Daniels was recognized as a “Rising Star” by the Women Tech Council at a luncheon in downtown Salt Lake City. The Women Tech Council focuses on accelerating the economic impact of women in technology and...
by Scott Larrivee | Oct 2, 2025 | Blog
Oct. 2, 2025 – The American Association for the Advancement of Science’s Science journal has published an overview article of the radiopharmaceuticals industry and Nusano is featured prominently. The publication writes: Nusano’s setup, a linear accelerator, is...
